Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Kras mutations and p53 overexpression in pseudomyxoma peritonei: association with phenotype and prognosis.

The Journal of surgical research - 1 Mar 2013

Shetty Shreya, Thomas Peter, Ramanan Bala, Sharma Poonam, Govindarajan Venkatesh, Loggie Brian

Abstract excerpt

BACKGROUND: Little information exists on Kras mutations and p53 overexpression in pseudomyxoma peritonei (PMP). These genetic alterations are associated with poorer prognoses in colorectal cancer. We postulated that these mutations might be more frequent in high-grade (HG) PMP (peritoneal mucinou...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Neoplasms
Share to Immunohistochemistry
Share to Peritoneal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prognosis

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 23199549
DOI: 10.1016/j.jss.2012.10.053

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23199549-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Kras mutations and p53 overexpression in pseudomyxoma peritonei: association with phenotype and prognosis.PMID 23199549Read ↗

Targeted Genetic Sequencing Analysis of 223 Cases of Pseudomyxoma Peritonei Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Shows Survival Related to GNAS and KRAS Status.Semantic proximity Read ↗

Genomic profile of pseudomyxoma peritonei analyzed using next-generation sequencing and immunohistochemistry.Semantic proximity Read ↗

Molecular profiles of high-grade and low-grade pseudomyxoma peritonei.Semantic proximity Read ↗

Appendix-derived Pseudomyxoma Peritonei (PMP): Molecular Profiling Toward Treatment of a Rare Malignancy.Semantic proximity Read ↗

TP53 Alterations Are an Independent Adverse Prognostic Indicator in Pseudomyxoma Peritonei of Appendiceal Origin Following Cytoreductive Surgery and Intraperitoneal Chemotherapy.Semantic proximity Read ↗

Mucinous and nonmucinous appendiceal adenocarcinomas: different clinicopathological features but similar genetic alterations.Semantic proximity Read ↗

Molecular Profiling of Low-Grade Appendiceal Mucinous Neoplasms (LAMN).Semantic proximity Read ↗

Toward the molecular dissection of peritoneal pseudomyxoma.Semantic proximity Read ↗

Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms.Semantic proximity Read ↗

Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women.Semantic proximity Read ↗

Pathological prognostic factors of pseudomyxoma peritonei: comprehensive clinicopathological analysis of 155 cases.Semantic proximity Read ↗

GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.